• 640 Citations
  • 12 h-Index
20052018
If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2012 PhD, Institute of Clinical Medicine, National Cheng Kung University

Experience

  • 2005.7~Present Attending Physician, Department of Internal Medicine, NCKUH
  • 2013.2~2015.8 Clinical Assistant professorr/Department of Internal Medicine, NCKU
  • 2015.8~present Assistant Professor/Institute of Clinical Medicine, NCKU

Research Interests

  • Clinical Oncology
  • Anti-Cancer Pharmacology
  • DNA Repair and Anti-Oxidant Stress in Oncology
  • Cellular Resistance to Anti-Cancer Therapy and its Clinical Application

Fingerprint Dive into the research topics where Wen-Pin Su is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Lung Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
STAT3 Transcription Factor Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Malignant Pleural Effusion Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2008 2018

Research Output 2005 2018

  • 640 Citations
  • 12 h-Index
  • 25 Article
  • 2 Letter

Excellent treatment response with pembrolizumab in a lung cancer patient who developed immune-mediated acute motor/sensory axonal polyneuropathy

Yen, C. C., Su, H-C., Chu, C-Y., Lai, S. J., Yan, J. J., Su, W-P. & Su, W-C., 2018 Jun 1, In : Lung Cancer. 120, p. 149-151 3 p.

Research output: Contribution to journalLetter

Polyneuropathies
Lung Neoplasms
Therapeutics
pembrolizumab
3 Citations (Scopus)

Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways

Su, W-P., Ho, Y. C., Wu, C. K., Hsu, S. H., Shiu, J. L., Huang, J. C., Chang, S-B., Chiu, W-T., Hung, J-J., Liu, T., Wu, W-S., Wu, P. Y., Su, W-C., Chang, J-Y. & Liaw, H-J., 2017 Dec 1, In : Scientific reports. 7, 1, 3879.

Research output: Contribution to journalArticle

Fanconi Anemia
Recombinational DNA Repair
Cisplatin
Fanconi Anemia Complementation Group D2 Protein
Genes
56 Citations (Scopus)
docetaxel
Platinum
Placebos
Carcinoma
Therapeutics
2 Citations (Scopus)

Combined interactions of plant homeodomain and chromodomain regulate NuA4 activity at DNA double-strand breaks

Su, W. P., Hsu, S. H., Chia, L. C., Lin, J. Y., Chang, S. B., Jiang, Z. D., Lin, Y. J., Shih, M. Y., Chen, Y. C., Chang, M. S., Yang, W. B., Hung, J. J., Hung, P. C., Wu, W. S., Myung, K. & Liaw, H., 2016 Jan, In : Genetics. 202, 1, p. 77-92 16 p.

Research output: Contribution to journalArticle

Double-Stranded DNA Breaks
Acetylation
Histones
Mutation
Bleomycin
11 Citations (Scopus)

Huntingtin-interacting protein-1 is an early-stage prognostic biomarker of lung adenocarcinoma and suppresses metastasis via AKT-mediated epithelial-mesenchymal transition

Hsu, C. Y., Lin, C. H., Jan, Y. H., Su, C. Y., Yao, Y. C., Cheng, H. C., Hsu, T. I., Wang, P. S., Su, W. P., Yang, C. J., Huang, M. S., Calkins, M. J., Hsiao, M. & Lu, P. J., 2016 Apr 15, In : American Journal of Respiratory and Critical Care Medicine. 193, 8, p. 869-880 12 p.

Research output: Contribution to journalArticle

Epithelial-Mesenchymal Transition
Biomarkers
Neoplasm Metastasis
Non-Small Cell Lung Carcinoma
Adenocarcinoma